2yog
From Proteopedia
(Difference between revisions)
(4 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | {{STRUCTURE_2yog| PDB=2yog | SCENE= }} | ||
- | ===Plasmodium falciparum thymidylate kinase in complex with a (thio)urea- alpha-deoxythymidine inhibitor=== | ||
- | {{ABSTRACT_PUBMED_23240776}} | ||
- | == | + | ==Plasmodium falciparum thymidylate kinase in complex with a (thio)urea- alpha-deoxythymidine inhibitor== |
- | [[2yog]] is a 2 chain structure with sequence from [ | + | <StructureSection load='2yog' size='340' side='right'caption='[[2yog]], [[Resolution|resolution]] 1.50Å' scene=''> |
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[2yog]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Plasmodium_falciparum_3D7 Plasmodium falciparum 3D7]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2YOG OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2YOG FirstGlance]. <br> | ||
+ | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.5Å</td></tr> | ||
+ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=74X:1-[4-CHLORANYL-3-(TRIFLUOROMETHYL)PHENYL]-3-[[(2R,3S)-5-[5-METHYL-2,4-BIS(OXIDANYLIDENE)PYRIMIDIN-1-YL]-3-OXIDANYL-OXOLAN-2-YL]METHYL]THIOUREA'>74X</scene></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2yog FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2yog OCA], [https://pdbe.org/2yog PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2yog RCSB], [https://www.ebi.ac.uk/pdbsum/2yog PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2yog ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/KTHY_PLAF7 KTHY_PLAF7] Catalyzes the phosphorylation of thymidine monophosphate (dTMP) to thymidine diphosphate (dTDP), the immediate precursor for the DNA building block dTTP (PubMed:18477629, PubMed:19126267, PubMed:31934749, PubMed:20353400). Can also phosphorylate dGMP and to a lesser extent GMP, dUMP and dIMP (PubMed:18477629, PubMed:19126267, PubMed:31934749, PubMed:20353400). Can use either ATP or dATP as phosphate donors in presence of Mg(2+) (PubMed:18477629).<ref>PMID:18477629</ref> <ref>PMID:19126267</ref> <ref>PMID:20353400</ref> <ref>PMID:31934749</ref> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Plasmodium falciparum thymidylate kinase (PfTMPK) is a key enzyme in pyrimidine nucleotide biosynthesis. 3-Trifluoromethyl-4-chloro-phenyl-urea-alpha-thymidine has been reported as an inhibitor of Mycobacterium tuberculosis TMPK (MtTMPK). Starting from this point, we designed, synthesized and evaluated a number of thymidine analogues as antimalarials. Both 5'-urea-alpha- and beta-thymidine derivatives were moderate inhibitors of PfTMPK and furthermore showed moderate inhibition of parasite growth. The structure of several enzyme-inhibitor complexes provides a basis for improved inhibitor design. However, we found that certain 5'-urea-alpha-thymidine analogues had antimalarial activity where inhibition of PfTMPK is not the major mode of action. Optimization of this series resulted in a compound with potent antimalarial activity (EC(50) = 28 nM; CC(50) = 29 muM). | ||
- | + | Synthesis and evaluation of alpha-thymidine analogues as novel antimalarials.,Cui H, Carrero-Lerida J, Silva AP, Whittingham JL, Brannigan JA, Ruiz-Perez LM, Read KD, Wilson KS, Gonzalez-Pacanowska D, Gilbert IH J Med Chem. 2012 Dec 27;55(24):10948-57. doi: 10.1021/jm301328h. Epub 2012 Dec, 14. PMID:23240776<ref>PMID:23240776</ref> | |
- | <ref | + | |
- | [[Category: | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> |
- | [[Category: | + | </div> |
- | [[Category: Brannigan | + | <div class="pdbe-citations 2yog" style="background-color:#fffaf0;"></div> |
- | [[Category: Carrero-Lerida | + | |
- | [[Category: Gilbert | + | ==See Also== |
- | [[Category: Gonzalez-Pacanowska | + | *[[Thymidylate kinase 3D structures|Thymidylate kinase 3D structures]] |
- | [[Category: Huaqing | + | == References == |
- | [[Category: Read | + | <references/> |
- | [[Category: Ruiz-Perez | + | __TOC__ |
- | [[Category: Silva | + | </StructureSection> |
- | [[Category: Whittingham | + | [[Category: Large Structures]] |
- | [[Category: Wilson | + | [[Category: Plasmodium falciparum 3D7]] |
- | + | [[Category: Brannigan JA]] | |
- | + | [[Category: Carrero-Lerida J]] | |
- | + | [[Category: Gilbert IH]] | |
+ | [[Category: Gonzalez-Pacanowska D]] | ||
+ | [[Category: Huaqing C]] | ||
+ | [[Category: Read KD]] | ||
+ | [[Category: Ruiz-Perez LM]] | ||
+ | [[Category: Silva APG]] | ||
+ | [[Category: Whittingham JL]] | ||
+ | [[Category: Wilson KS]] |
Current revision
Plasmodium falciparum thymidylate kinase in complex with a (thio)urea- alpha-deoxythymidine inhibitor
|